XM does not provide services to residents of the United States of America.
E
E

EDPRenovaveis

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

EDPR Secures Long-Term Contract For 75 MW Of Storage In Canada

BRIEF-EDPR Secures Long-Term Contract For 75 MW Of Storage In Canada June 12 (Reuters) - EDP Renovaveis SA EDPR.LS : SAID ON TUESDAY IT SECURED 20-YEAR LONG-TERM RELIABILITY SERVICES 1 CONTRACT IN CANADA CONTRACT TO SELL ENERGY, CAPACITY AND ANCILLARY SERVICES DELIVERED FROM 75 MWAC (300MWH) EDGEWARE BESS BATTERY STORAGE FACILITY CONTRACT THROUGH EDP RENEWABLES NORTH AMERICA WITH ONTARIO INDEPENDENT ELECTRICITY SYSTEM OPERATOR PROJECT, LOCATED IN CITY OF ST.
E

Jefferies cuts EDPR to 'hold', reiterates 'buy' for EDP

BUZZ-Jefferies cuts EDPR to 'hold', reiterates 'buy' for EDP ** Jefferies downgrades Portugal's wind energy producer EDP Renovaveis EDPR.LS to "hold" from "buy" as current valuations limit its potential upside ** The brokerage believes that current holding discount (c.27%) to EDPR's market value is excessive and remains cautious because of expected
E
E

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

MS ups Acciona Energia on power prices rebound, asset rotation deals

BUZZ-MS ups Acciona Energia on power prices rebound, asset rotation deals ** Morgan Stanley upgrades Spain's Acciona Energia ANE.MC to "equal-weight" from "underweight" citing expected power prices rebound and asset rotation deals in the second half of the year that could balance risk-reward profile and provide more clarity on leverage ** It says d
A
E

Ascential, Cellnex, Wise

EUROPE RESEARCH ROUNDUP- Ascential, Cellnex, Wise May 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Ascential, Cellnex and Wise on Tuesday. HIGHLIGHTS * Ascential ASCL.L : Berenberg re-initiates coverage with buy rating; target price 395p * Burberry BRBY.L : Barclays cuts target price to 1090p from 1340p * Cellnex CLNX.MC : Berenberg raises to buy from hold * Trainline TRNT.L : Deutsche Bank initiates coverage with buy rating a
3
B
B
B
B
B
B
C
C
C
C
D
E
E
F
H
H
L
N
R
S
S
S
S
U
B
E
I
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.